A comparative meta-analysis on the variability in test performance among FDA-licensed enzyme immunosorbent assays for HIV antibody testing

Journal of Clinical Epidemiology

Volumn 54, Issue 5, 2001, Pages 448-461

  Kowalski, J ^a   Tu, X M ^b   Jia, G ^c   Pagano, M ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Diagnostic test; Enzyme immunosorbent assay; HIV; Meta analysis

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ARTICLE; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; META ANALYSIS; PRIORITY JOURNAL; STATISTICAL MODEL;

BAYES THEOREM; DEVICE APPROVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; SENSITIVITY AND SPECIFICITY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0035031434     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(00)00320-6     Document Type: Article

References (53)

1. Use and interpretation of diagnostic immunologic laboratory tests
2. Human Immunodeficiency Virus test evaluation, performance, and use
3. Quality of laboratory performance in testing for Human Immunodeficiency Virus Type I antibody; identification of variables associated with laboratory performance
4. The use of meta-analysis in technology assessment; a meta-analysis of the enzyme immunosorbent assay Human Immunodeficiency Virus antibody test
5. A meta-analytic evaluation of the polymerase chain reaction for the diagnosis of HIV infection in infants
6. Selection models and the file drawer problem
7. Summary of the Centers for Disease Control Human Immunodefficiency Virus (HIV) performance evaluation surveys for 1985 and 1986
8. Update; Serologic Testing for Antibody to Human Immunodeficiency Virus
9. Analytic sensitivity and specificity of enzyme immunoassay results in testing for human immunodeficiency virus Type 1 antibody
10. Indirect immunofluorescence test performance and questionnaire results from the Centers for Disease Control model performance evaluation program for Human Immunodeficiency Virus Type 1 testing
11. Issues in HIV screening programs
12. Feinstein A. Use of methodological standards in diagnostic test research
13. Guidelines for meta-analyses evaluating diagnostic tests
14. The poor quality of early evaluations of magnetic resonance imaging
15. The fugitive literature
16. Comparison of 10 enzyme immunoassays for detection of antibody to Human Immunodeficiency Virus type 2 in West African Sera
17. Comparative evaluation of 36 commercial assays for detecting antibodies to HIV
18. Sources of confounding immunologic data
19. Human Immunodeficiency Virus Type 2 infection in the United States; epidemiology, diagnosis, and public health implications
20. Point estimation of the parameter of the binomial distribution
21. Combining independent studies of a diagnostic test into a summary ROC curve; data-analytic approaches and some additional considerations
22. The statistical precision of medical screening procedures; applications to polygraph and AIDS antibodies test data
23. On the informativeness and accuracy of pooled testing in estimating prevalence for a rare disease; application to HIV screening
24. Bayesian inference on prevalence using a missing-data approach with simulation-based techniques; applications to HIV screening
25. Bayesian analysis of prevalence with covariates using simulation-based techniques; applications to HIV screening
26. Serum-pooling strategies for HIV screening; experiences in Dominican Republic, Trinidad, Ecuador, and the Philippines
27. Multicenter evaluation of a fully automated screening test, VIDAS HIV 1+2, for antibodies to Human Immunodeficiency Virus Types 1 and 2
28. Evaluation of three commercial screening tests for AIDS virus antibodies
29. Diagnostic usefulness of five screening assays for HIV in an East African city where prevalence of infection is low
30. Relative specificity of enzyme-linked immunosorbent assays for antibodies to human T-cell lymphotrophic virus, type III, and their relationship to Western Blotting
31. Performance of serological assays for early detection of Human Immunodeficiency Virus Type I seroconversion
32. Anti-HTLV-III testing of blood donors; reproducibility and confirmability of commercial test kits
33. Human immunodeficiency virus (HIV) antibodies detected by new assays that are enhanced for HIV-1 subtype O
34. An evaluation of competitive and second generation ELISA screening tests for antibody to HIV
35. Detection of Human Immunodeficiency Virus (HIV) Type 1 antibodies by new automated microparticle enzyme immunoassays for HIV Types 1 and 2
36. Multisite evaluation of four Anti-HIV-1/HIV-2 enzyme immunoassays
37. Alternative confirmatory strategies in HIV-1 antibody testing
38. Simplified and less expensive confirmatory HIV testing
39. Evaluation of an aggultination HIV-1+2 antibody assay
40. Evaluation of the automated enzymen-test anti HIV-1+2 and enzymen-test Anti HIV-1/2 selective for the combined detection and differentiation of anti-HIV-1 and anti-HIV-2 antibodies
41. Evaluation of the reliability of 6 current anti-HIV-1/HIV-2 enzyme immunoassays